XASXEZZ
Market cap89mUSD
Dec 27, Last price
3.05AUD
1D
0.00%
1Q
-24.50%
IPO
199.02%
Name
EZZ Life Science Holdings Ltd
Chart & Performance
P/E
20.66
P/S
2.17
EPS
0.15
Div Yield, %
0.75%
Shrs. gr., 5y
0.51%
Rev. gr., 5y
42.81%
Revenues
66m
+78.88%
Net income
7m
+91.87%
CFO
6m
+53.05%
Dividend
May 16, 20240.015 AUD/sh
Profile
EZZ Life Science Holdings Limited provides skin care and consumer health products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned products. It is involved in the wholesale distribution of EAORON branded skin care products to pharmacies, supermarkets, and specialist retailers, as well as grocery retailers. The company also designs, develops, produces, distributes, and sells consumer health products, including vitamins and dietary supplements, sports nutrition, weight management and wellbeing, herbal/traditional, and paediatric products under the EZZ brand through its e-commerce platforms and stores, such as Tmall Global. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | |
| Income | ||||||
Revenues | 66,443 78.88% | 37,143 147.26% | 15,022 -32.60% | |||
Cost of revenue | 55,645 | 31,643 | 11,378 | |||
Unusual Expense (Income) | ||||||
NOPBT | 10,799 | 5,500 | 3,644 | |||
NOPBT Margin | 16.25% | 14.81% | 24.26% | |||
Operating Taxes | 2,995 | 1,271 | 467 | |||
Tax Rate | 27.73% | 23.11% | 12.83% | |||
NOPAT | 7,804 | 4,229 | 3,176 | |||
Net income | 6,964 91.87% | 3,630 176.57% | 1,312 -35.37% | |||
Dividends | (1,082) | (600) | (173) | |||
Dividend yield | 1.36% | 2.81% | 1.31% | |||
Proceeds from repurchase of equity | 854 | |||||
BB yield | -1.07% | |||||
| Debt | ||||||
Debt current | 124 | 355 | 105 | |||
Long-term debt | 124 | 248 | 105 | |||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | (18,775) | (13,851) | (10,423) | |||
| Cash flow | ||||||
Cash from operating activities | 6,144 | 4,014 | 1,902 | |||
CAPEX | (409) | (102) | (13) | |||
Cash from investing activities | (441) | (102) | (13) | |||
Cash from financing activities | (582) | (762) | (277) | |||
FCF | 5,389 | 3,975 | 3,393 | |||
| Balance | ||||||
Cash | 19,023 | 13,831 | 10,465 | |||
Long term investments | 623 | 168 | ||||
Excess cash | 15,700 | 12,596 | 9,881 | |||
Stockholders' equity | 21,323 | 14,582 | 11,387 | |||
Invested Capital | 5,746 | 2,172 | 1,368 | |||
ROIC | 197.11% | 238.96% | 181.91% | |||
ROCE | 50.23% | 37.24% | 32.22% | |||
| EV | ||||||
Common stock shares outstanding | 43,083 | 42,705 | 42,510 | |||
Price | 1.85 270.00% | 0.50 61.29% | 0.31 -30.34% | |||
Market cap | 79,704 273.28% | 21,352 62.03% | 13,178 -29.49% | |||
EV | 60,929 | 7,502 | 2,755 | |||
EBITDA | 11,190 | 5,682 | 3,762 | |||
EV/EBITDA | 5.44 | 1.32 | 0.73 | |||
Interest | 25 | 10 | 4 | |||
Interest/NOPBT | 0.23% | 0.19% | 0.12% | |||